Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma

NCT00983944 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Inadequate Accrual

Conditions

Lymphoma

Interventions

BIOLOGICAL: bleomycin sulfate
BIOLOGICAL: rituximab
DRUG: EPOCH regimen
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: prednisone
DRUG: vincristine sulfate

Sponsor

Ohio State University Comprehensive Cancer Center